Corcept Therapeutics | CORT - Операционный доход

Биржевая цена
41.57
Изменение за день
0.72 1.76%
Ежемесячно
22.30%
Ежегодный
-41.03%
Q2 прогноз
41.21




Операционный доход Изменить Дата
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Ardelyx USD 5.1M 431K 2025-12
Assertio Holdings USD -3.05M 569K 2024-09
Aurora Cannabis CAD -35.79M 19.88M 2025-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
J&J USD 5.59B 1.81B 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Merck USD 6.24B 318M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novartis USD 4.06B 437M 2025-12
Novartis USD 4.06B 521M 2025-12
Omeros USD -35.41M 23.75M 2024-09
Pacira USD 3.19M 9.96M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
TG Therapeutics USD 50.49M 21.13M 2025-12